glp-1 dementia news Blood Flow to Brain Function: How Therapies May Reduce Risk Research shows treatments like Semaglutide

Regulation of insulin synthesis and secretion and pancreatic Beta-cell dysfunction in diabetes

Topline data from their MASH trial is expected this summer, and the alcohol liver disease trial will begin enrolling in the fall

Preventing Nutritional Deficiencies People struggling with their weight are already at risk of suboptimal dietary patterns if they have pursued or are pursuing intentional weight loss because of reduced food intake and sometimes, insufficient calorie and nutrient intake

WASHINGTON (TNND) GLP-1 medications have transformed the way doctors treat obesity in adults but as demand grows, a new question is emerging: how young is too young to use these drugs